EmamiQ1 FY27
Emami Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹402P/E: 23.2Market Cap: ₹17.6K CrSector: Personal Products
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13).
- →Management expects better growth in core business for the remainder of the year (Rajesh Sharma, pg 13).
- →Strategic investments portfolio grew 61% and expected to sustain similar growth going forward (Dhruv Aggarwal, pg 5).
- →Start-ups like The Man Company, Brillare showing strong momentum with plans for new launches and expansion (pg 7, 11).
- →Kesh King expected to achieve double-digit growth by year-end after mid-single-digit growth in Q1 (Mohan Goenka, pg 11).
- →International business faced challenges but expected significant recovery and growth in Q3 and Q4 (pg 7).
- →Overall consolidated revenue grew 15% in Q1, signaling positive trajectory (Mohan Goenka, pg 3).
- →Management confident of sustained and profitable growth through FY27 supported by diversified portfolio and innovation (pg 5).
Margin guidance
Category 3- →Core domestic business growth expected to improve beyond current ~6% (Rajesh Sharma, page 13).
- →Strategic investments (start-ups) growing strongly (~20%-30% growth), with EBITDA margins targeting low teens within 2-3 years (Dhruv Aggarwal, pages 9-10).
- →International business anticipated to recover strongly in Q3 and Q4 after Middle East disruptions (Mohan Goenka, page 7).
- →Margins pressure short-term due to West Asia issues and inflation but expected to bounce back with price hikes and cost actions; commitment to maintain margins around 20%-22% excluding other income (Mohan Goenka, pages 10-11).
- →EBITDA grew by 6% in Q1 despite inflation; profitability expected to improve with ongoing cost measures (page 4).
- →EPS expected to improve with better execution, channel transformation, and diversification.
3 more insights locked — sign up free to unlock
Fundraise plans
- →There is no mention of any new fundraising through debt or equity in the transcript.
- →The INR 500 crores investment in Axiom was funded internally from the company's surplus.
- →Rajesh Sharma confirmed that payments for acquisitions have been made/internal funded, implying no external borrowing.
- →Management is focused on internal funding and disciplined cost management without indicating plans for fresh debt or equity issuance.
- →The company is open to further acquisitions in strategic investments but has not disclosed specific plans for raising external funds.
Order book
The transcript provided does not explicitly mention any details regarding the current or expected orderbook or pending orders for Emami Limited as of Q1 FY27. However, some related points can be inferred:
- International business order execution faced challenges due to West Asia conflict and supply chain disruptions, especially for OTC pain management products.
- The company is working to resolve regulatory approvals to move pain management products from India to Middle East markets.
- Once resolved, management expects to regain momentum and see significant growth in international markets in Q3 and Q4 FY27.
- There is no direct mention of specific orderbook values or pending orders.
- The company remains optimistic about growth prospects due to diversified portfolio and ongoing strategic initiatives.
If you need detailed orderbook data, it may not be available in this transcript.
Capex plans
Yes- →Emami has made a significant strategic investment, including about INR 500 crores in Axiom, funded internally from surplus cash.
- →The company plans further investments in strategic start-ups and fast-growing segments, with a committed management focus on such acquisitions.
- →The strategic investment division, including four start-ups, is expected to grow aggressively, targeting INR 750-800 crores revenue by year-end.
- →Emami is actively scouting for incremental acquisition opportunities alongside consolidating recent ones.
- →They are enhancing supply chain planning, inventory management, and distribution visibility and implementing AI-driven sales code systems to improve operational efficiency.
- →Future capex is likely focused on strengthening the diversified portfolio, digital-first brands, e-commerce, and modern trade channels, as implied by ongoing transformation initiatives.
- →The organization may bolster the central team to support strategic investments growth and plug-and-play scaling models.
How does Emami rank vs peers in Personal Products?
Pro feature1Emami
Rev 3Mar 3
See full Personal Products sector rankings
How does Emami rank in Personal Products?
Compare Emami against every Personal Products company (Q1 FY27) on revenue, margins and earnings-call signals.